Core Viewpoint - The company Innotech has introduced new products that cater to both B2B and B2C markets, providing testing solutions for professional medical personnel and consumers alike [1] Product Offerings - The new product line includes a respiratory series that features combined antigen test kits for respiratory syncytial virus, adenovirus, parainfluenza virus, and others using latex chromatography [1] - Additionally, the product range includes antigen test kits for influenza A and B viruses, as well as the novel coronavirus (2019-nCoV), also utilizing latex methods [1] - Other offerings consist of fecal occult blood (FOB) test kits using colloidal gold immunochromatography and Helicobacter pylori antigen test kits employing latex methods [1]

Core Viewpoint - Innotech is actively developing home testing business to meet the emerging market demand for respiratory and digestive applications, enhancing its online marketing efforts through official flagship stores and other platforms [2] Group 1: Company Overview - Innotech received an institutional research visit from Tianhong Fund on December 9, 2025, with the meeting conducted online [1] - The company’s board secretary, Chen Fukan, represented Innotech during the research meeting [2] Group 2: Product Development - Innotech's new products cater to both B-end and C-end markets, suitable for professional medical personnel and consumer self-testing [2][5] - The product lineup includes respiratory series products (e.g., combined antigen test kits for respiratory syncytial virus, adenovirus, etc.) and digestive-related products (e.g., fecal occult blood test kits, Helicobacter pylori antigen test kits) [2][6] Group 3: Sales Channels and Competitive Advantage - The C-end sales channels are primarily online, including authorized stores and self-operated flagship stores on platforms like JD.com, Taobao, and Meituan [4] - The company has established a certain level of brand recognition in the domestic respiratory pathogen detection field due to years of technical accumulation and market expansion [4] Group 4: Investment Strategy - Innotech focuses its external investments on areas that are highly synergistic with its main business, including new products, new technology platforms, and new testing fields [7] - The company conducts careful assessments and decision-making regarding related projects, with progress updates to be disclosed in accordance with regulatory requirements [7]